NICE guidance
Metreleptin recommended to treat lipodystrophy
Positive recommendation in NICE draft guidance follows receipt of additional information and extensive liaison with the company.
Anakinra provisionally recommended for Still’s disease
In its draft guidance, NICE recommends the treatment in specific cases as an option for treating Still’s disease with moderate to high disease activity, or continued disease activity after NSAIDs or glucocorticoids.
NICE updates guidelines following a Public Health England evidence review on dependence on, and withdrawal from, prescribed medicines
Updates included in osteoarthritis, peripheral arterial disease, and low back pain and sciatica guidelines.
NICE updates guidelines following MHRA Drug Safety Update on insulins
Updates included in eating disorders, pancreatitis and diabetes guidelines.